Invicta Diagnostic Ltd

NSE: INVICTA · Healthcare · 36 announcements

Share price: ₹74.50
Market cap: ₹93.66 Cr
Revenue (annual): ₹32.35 Cr
Net profit (annual): ₹4.91 Cr
P/E (TTM): 19.1×Sector 54.5×
Promoter holding: 66.70%
FII holding: 1.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 4 Management Change 4 Financial Results 3 Board Meeting Outcome 3 Production Started 2 Earnings Call 2 Board Meeting Date 2 Annual General Meeting 2 Results Update 1 Product Launch 1 Fund Raise 1 Capacity Expansion 1 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

25 May 2026 20:36 IST NSE

Financial Results

Invicta Diagnostic Financial Results

Invicta Diagnostic reported standalone total income of ₹21.41 Crore for FY26. The board approved audited results with an unmodified opinion from statutory auditors.

Value: ₹21.41 Cr

Open announcement → Read the filing ↗

18 May 2026 13:28 IST NSE

Financial Results

Invicta Diagnostic H2 FY26 Results: Net Profit ₹0.8 Cr, Down 80.5% QoQ

Invicta Diagnostic Ltd reported revenue from operations of ₹15.4 Cr and net profit of ₹0.8 Cr for H2 FY26.

Key figure: Net profit ₹0.8 Cr

Open full results → Read the filing ↗

18 May 2026 13:27 IST NSE

Financial Results

Invicta Diagnostic Financial Results

Invicta Diagnostic Limited reported audited financial results for fiscal year 2026. The Board approved standalone and consolidated statements showing steady performance across its diagnostic centers.

Open announcement → Read the filing ↗